WeVote
Log In

Bill

Bill

SB 42

Authorizing over-the-counter sale of ivermectin

2026 Regular Session Introduced by Mike Azinger and 4 co-sponsors

West Virginia bill would permit over-the-counter purchase of ivermectin, removing prescription requirement for the antiparasitic drug despite FDA's prescription-only classification.

To Judiciary
#health
0
WeVote Research Nonpartisan
Bill Summary · SB 42

Legislative bill overview

SB 42 would allow ivermectin, a prescription antiparasitic medication, to be purchased over-the-counter in West Virginia without a doctor's prescription. The bill has passed initial review and is currently in the Judiciary Committee after being reviewed by Health and Human Resources.

Why is this important

Ivermectin availability affects both parasite treatment access and public health messaging, as the drug gained significant attention during COVID-19 when some promoted it as an unproven coronavirus treatment. This change would alter the regulatory framework governing a widely-used medication and represents a shift toward less restrictive pharmaceutical access in West Virginia.

Potential points of contention

  • Medical oversight removal: OTC status eliminates doctor evaluation for appropriate use, dosing, and contraindications, potentially increasing misuse or adverse effects in vulnerable populations
  • COVID-19 context: The bill emerges amid ongoing controversy over ivermectin promotion for COVID-19 despite lack of clinical evidence, raising concerns about enabling unproven treatments
  • FDA authority conflict: Federal law classifies ivermectin as prescription-only; state OTC authorization may create legal and regulatory complications with federal drug approval processes
  • Public health messaging: Easier access could reinforce misinformation about ivermectin's effectiveness for non-parasitic conditions and complicate disease treatment guidance

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.